CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sonneveld, E.
Right arrow Articles by van der Saag, P. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sonneveld, E.
Right arrow Articles by van der Saag, P. T.

Cell Growth & Differentiation, Vol 9, Issue 8 629-637, Copyright © 1998 by American Association of Cancer Research


ARTICLES

Human retinoic acid (RA) 4-hydroxylase (CYP26) is highly specific for all-trans-RA and can be induced through RA receptors in human breast and colon carcinoma cells

E Sonneveld, CE van den Brink, BM van der Leede, RK Schulkes, M Petkovich, B van der Burg and PT van der Saag
Hubrecht Laboratory, Netherlands Institute for Developmental Biology, Utrecht.

We report on the isolation of a cytochrome P450 (CYP)-like retinoic acid (RA) 4-hydroxylase cDNA from T-47D human breast cancer cells that is identical to the recently cloned hCYP26, which is involved in the metabolic breakdown of RA. Northern analysis showed that this novel human CYP26 is induced within 1 h upon RA treatment in RA-sensitive T-47D breast carcinoma cells but not in RA-resistant MDA-MB-231 breast cancer cells and HCT 116 colon cancer cells. Stable introduction of different RA receptor (RAR) subtypes in HCT 116 cells showed that CYP26 expression is dependent on RARalpha and RARgamma and, to a lesser extent, on RARbeta and closely paralleled RA metabolism, suggesting that it represents the major RA 4-hydroxylase in these human cells. Furthermore, stable introduction of all three RAR subtypes in HCT 116 cells resulted in restored RA sensitivity as assayed by growth inhibition. Interestingly, CYP26 activity was efficiently inhibited by liarozole, an inhibitor of RA metabolism, leading to enhanced growth inhibition by RA. The RA-induced CYP26 was shown to be highly specific for the hydroxylation of all-trans-RA and did not recognize the 13-cis and 9-cis isomers. This substrate specificity is promising for finding retinoids that are not recognized by this enzyme and, therefore, could be more effective in growth inhibition of susceptible cancer cells.


This article has been cited by other articles:


Home page
J. Cell Sci.Home page
H. J. Dranse, A. V. Sampaio, M. Petkovich, and T. M. Underhill
Genetic deletion of Cyp26b1 negatively impacts limb skeletogenesis by inhibiting chondrogenesis
J. Cell Sci., August 15, 2011; 124(16): 2723 - 2734.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. E. Thatcher, B. Buttrick, S. A. Shaffer, J. A. Shimshoni, D. R. Goodlett, W. L. Nelson, and N. Isoherranen
Substrate Specificity and Ligand Interactions of CYP26A1, the Human Liver Retinoic Acid Hydroxylase
Mol. Pharmacol., August 1, 2011; 80(2): 228 - 239.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Wang, X. Ma, K. W. Krausz, J. R. Idle, and F. J. Gonzalez
Role of Pregnane X Receptor in Control of All-Trans Retinoic Acid (ATRA) Metabolism and Its Potential Contribution to ATRA Resistance
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 674 - 684.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Saurer, K. C. McCullough, and A. Summerfield
In Vitro Induction of Mucosa-Type Dendritic Cells by All-Trans Retinoic Acid
J. Immunol., September 15, 2007; 179(6): 3504 - 3514.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
G. S. Gorman, L. Coward, C. Kerstner-Wood, L. Cork, I. M. Kapetanovic, W. J. Brouillette, and D. D. Muccio
In Vitro Metabolic Characterization, Phenotyping, and Kinetic Studies of 9cUAB30, a Retinoid X Receptor-Specific Retinoid
Drug Metab. Dispos., July 1, 2007; 35(7): 1157 - 1164.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
X.-H. Tang, M.-J. Suh, R. Li, and L. J. Gudas
Cell proliferation inhibition and alterations in retinol esterification induced by phytanic acid and docosahexaenoic acid
J. Lipid Res., January 1, 2007; 48(1): 165 - 176.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. N. Shelton, I. T. Sandoval, A. Eisinger, S. Chidester, A. Ratnayake, C. M. Ireland, and D. A. Jones
Up-regulation of CYP26A1 in Adenomatous Polyposis Coli-Deficient Vertebrates via a WNT-Dependent Mechanism: Implications for Intestinal Cell Differentiation and Colon Tumor Development.
Cancer Res., August 1, 2006; 66(15): 7571 - 7577.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Gaillard, N. Bruck, Y. Brelivet, G. Bour, S. Lalevee, A. Bauer, O. Poch, D. Moras, and C. Rochette-Egly
Phosphorylation by PKA potentiates retinoic acid receptor {alpha} activity by means of increasing interaction with and phosphorylation by cyclin H/cdk7
PNAS, June 20, 2006; 103(25): 9548 - 9553.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Y. Park, A. Dillard, E. A. Williams, E. T. Wilder, M. R. Pepper, and M. A. Lane
Retinol Inhibits the Growth of All-Trans-Retinoic Acid-Sensitive and All-Trans-Retinoic Acid-Resistant Colon Cancer Cells through a Retinoic Acid Receptor-Independent Mechanism
Cancer Res., November 1, 2005; 65(21): 9923 - 9933.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. J. Donato and N. Noy
Suppression of Mammary Carcinoma Growth by Retinoic Acid: Proapoptotic Genes Are Targets for Retinoic Acid Receptor and Cellular Retinoic Acid-Binding Protein II Signaling
Cancer Res., September 15, 2005; 65(18): 8193 - 8199.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. C. Ross and R. Zolfaghari
Regulation of Hepatic Retinol Metabolism: Perspectives from Studies on Vitamin A Status
J. Nutr., January 1, 2004; 134(1): 269S - 275.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. Liu, R. M. Russell, and X.-D. Wang
Exposing Ferrets to Cigarette Smoke and a Pharmacological Dose of {beta}-Carotene Supplementation Enhance In Vitro Retinoic Acid Catabolism in Lungs via Induction of Cytochrome P450 Enzymes
J. Nutr., January 1, 2003; 133(1): 173 - 179.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. C. Ross
Retinoid Production and Catabolism: Role of Diet in Regulating Retinol Esterification and Retinoic Acid Oxidation
J. Nutr., January 1, 2003; 133(1): 291S - 296.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. V. Chithalen, L. Luu, M. Petkovich, and G. Jones
HPLC-MS/MS analysis of the products generated from all-trans-retinoic acid using recombinant human CYP26A
J. Lipid Res., July 1, 2002; 43(7): 1133 - 1142.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Guo, B. S. Knudsen, D. M. Peehl, A. Ruiz, D. Bok, R. R. Rando, J. S. Rhim, D. M. Nanus, and L. J. Gudas
Retinol Metabolism and Lecithin:Retinol Acyltransferase Levels Are Reduced in Cultured Human Prostate Cancer Cells and Tissue Specimens
Cancer Res., March 1, 2002; 62(6): 1654 - 1661.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Cerignoli, X. Guo, B. Cardinali, C. Rinaldi, J. Casaletto, L. Frati, I. Screpanti, L. J. Gudas, A. Gulino, C. J. Thiele, et al.
retSDR1, a Short-Chain Retinol Dehydrogenase/Reductase, Is Retinoic Acid-inducible and Frequently Deleted in Human Neuroblastoma Cell Lines
Cancer Res., February 1, 2002; 62(4): 1196 - 1204.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
A. Lampen, S. Meyer, and H. Nau
Effects of Receptor-Selective Retinoids on CYP26 Gene Expression and Metabolism of All-trans-Retinoic Acid in Intestinal Cells
Drug Metab. Dispos., April 13, 2001; 29(5): 742 - 747.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
I. Klaassen, R. H. Brakenhoff, S. J. Smeets, G. B. Snow, and B. J. M. Braakhuis
Enhanced Turnover of all-trans-Retinoic Acid and Increased Formation of Polar Metabolites in Head and Neck Squamous Cell Carcinoma Lines Compared with Normal Oral Keratinocytes
Clin. Cancer Res., April 1, 2001; 7(4): 1017 - 1025.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
X. Guo, D. M Nanus, A. Ruiz, R. R Rando, D. Bok, and L. J Gudas
Reduced Levels of Retinyl Esters and Vitamin A in Human Renal Cancers
Cancer Res., March 1, 2001; 61(6): 2774 - 2781.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Lampen, S. Meyer, T. Arnhold, and H. Nau
Metabolism of Vitamin A and Its Active Metabolite All-trans-retinoic Acid in Small Intestinal Enterocytes
J. Pharmacol. Exp. Ther., December 1, 2000; 295(3): 979 - 985.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
S. Y. Kim, H. Adachi, J. S. Koo, and A. M. Jetten
Induction of the Cytochrome P450 Gene CYP26 during Mucous Cell Differentiation of Normal Human Tracheobronchial Epithelial Cells
Mol. Pharmacol., September 1, 2000; 58(3): 483 - 490.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. Stoppie, M. Borgers, P. Borghgraef, L. Dillen, J. Goossens, G. Sanz, H. Szel, C. Van Hove, G. Van Nyen, G. Nobels, et al.
R115866 Inhibits All-trans-Retinoic Acid Metabolism and Exerts Retinoidal Effects in Rodents
J. Pharmacol. Exp. Ther., April 1, 2000; 293(1): 304 - 312.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
Q.-Y. Zhang, D. Dunbar, and L. Kaminsky
Human Cytochrome P-450 Metabolism of Retinals to Retinoic Acids
Drug Metab. Dispos., March 1, 2000; 28(3): 292 - 297.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1998 by the American Association of Cancer Research.